Home

We partner with early stage ventures to build companies that transform lives and industries.

About Us

Since 1962, Elron has been at the forefront of Israeli innovation, as founders and early investors in companies such as Elbit Systems, Elscint, Zoran, Partner, Netvision and Given Imaging.

Today we remain committed to our vision of identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders.

Our team is dedicated to attracting and supporting imaginative and focused entrepreneurs and startups with never-been-done-before ideas. Group companies benefit from our combined technological, strategic, entrepreneurial & business expertise, broad networks, and wide attention span.

A word from our founder

Where We Invest

We invest in treatment-changing (rather than treatment-enhancing) medical device companies. We seek companies with billion-$ market potential. We usually invest in the idea/R&D stage.
We invest in exceptional ideas and technologies with the potential to transform or create new markets, and help make the world a more secure place to live in. We seek investment opportunities from seed to growth stages.

RDC

Strategic JV

RDC was founded in 1993 by Elron and Rafael, a global leader of defense technologies and one of Israel's largest defense companies. RDC combines Rafael's scale and technological edge, with Elron's vast expertise in helping startups develop into leading tech companies.

Through RDC, which has exclusive rights to commercialize Rafael's defense technologies in civilian markets, we initiate and develop new companies, and provide essential support from start to exit.

Since its inception, RDC has successfully invested in numerous hi-tech companies. A prime example of RDC's active end-to-end involvement in the growth of its companies is Given Imaging. Given Imaging redefined gastrointestinal disease diagnosis by developing the PillCam ingestible video capsule, based on a unique technology initially invented for military purposes. After becoming a world leader in its field, Given Imaging was acquired for $1 billion.

How We Invest

We aim high.

We invest primarily in early stage ventures with significant exit potential, in which we seek significant shareholder stakes, enabling us to provide hands-on support and contribute from our experience.

We become involved.

We play a defining role in the development of our group companies, by means of active involvement in all aspects of their business and day-to-day operations, to help them reach their long-term objectives.

We are committed.

As an operational holding company that invests its own capital in new and existing group companies, we have the flexibility to support the growth of our group companies over the long term, weather setbacks, and maximize exit events.

Key Stats

$1.5b

value of exit transactions since 2010

$243m

investments since 2010

$140m

dividends distributed since 2010

12

M&As since 2010

$209m

total amount invested in current group companies

News

More news

Pioneer of Next Generation Email Security, IRONSCALES, Closes $15 Million Series B Led by K1; Approaches 1,000 Customers Worldwide

June 17, 2019

K1 Investment Management returns to support anti-phishing innovator’s mission to help organizations where email security hurts most, with post-message delivery detection and response

Read More

CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA

June 12, 2019

“We are very pleased from the fact that the top surgeons in the world have elected to participate in our clinical study and that the enrollment rate is exceeding our expectations,” said Nir Altschuler, CartiHeal’s founder and CEO

Read More

Cynerio Honored with 2019 MedTech Breakthrough Award

June 10, 2019

CyberSecurity Solution Recognized for Protection of Medical Devices Based on Deep Understanding of Clinical Workflows

Read More
More news